国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Human Roundabout homolog 3 (ROBO3), partial CSB-EP846671HU1 1mg/100ug/20ug
Recombinant Human Transcriptional enhancer factor TEF-5 (TEAD3), partial CSB-EP860344HUd7 1mg/100ug/20ug
Recombinant Human Transcriptional enhancer factor TEF-3 (TEAD4), Partial CSB-EP618010HU1g5 1mg/100ug/20ug
Recombinant Human Vimentin (VIM) CSB-EP025857HUc7 1mg/100ug/20ug
Recombinant Human Surfactant-associated protein 2 (SFTA2) CSB-EP754403HUc7 1mg/100ug/20ug
Recombinant Klebsiella pneumoniae subsp. pneumoniae Penicillin-binding protein 1B, partial CSB-EP6059GNAd7 1mg/100ug/20ug
Recombinant Human Protein-lysine 6-oxidase (LOX), partial CSB-EP013038HU1 1mg/100ug/20ug
Recombinant Mouse Protein Wnt-3a (Wnt3a) CSB-EP026136MOc7 1mg/100ug/20ug
Recombinant Human E3 ubiquitin-protein ligase TRIM21 (TRIM21) CSB-EP024457HUc7 1mg/100ug/20ug
Recombinant Mouse Apoptosis-associated speck-like protein containing a CARD (Pycard) CSB-EP861664MOc7 1mg/100ug/20ug
Recombinant Human Protein Wnt-3a (WNT3A), partial CSB-EP026136HU1c7 1mg/100ug/20ug
Recombinant Danio rerio Aerolysin-like protein (aep1) CSB-EP710693DIL 1mg/100ug/20ug
Recombinant Streptococcus sp. group G Immunoglobulin G-binding protein G (spg), partial CSB-EP322577SNDb0(F10) 1mg/100ug/20ug
Recombinant Influenza B virus Nucleoprotein (NP), partial CSB-EP319610IIRc7 1mg/100ug/20ug
Recombinant Human Transcriptional enhancer factor TEF-3 (TEAD4), partial CSB-EP618010HU1a0 1mg/100ug/20ug
Recombinant Human Fibroblast growth factor 10 (FGF10), partial CSB-EP008616HU1c7 1mg/100ug/20ug
Recombinant Human Lysosomal acid glucosylceramidase (GBA1) CSB-EP009289HUa2 1mg/100ug/20ug
Recombinant Human Transcriptional enhancer factor TEF-4 (TEAD2), partial CSB-EP613597HU2d7 1mg/100ug/20ug
Recombinant Drosophila melanogaster Tyrosine-protein kinase hopscotch (hop), partial CSB-EP631547DLUg5 1mg/100ug/20ug
Recombinant Human Transcriptional enhancer factor TEF-3 (TEAD4), Partial CSB-EP618010HU1d7 1mg/100ug/20ug

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>